SKI Market

Indian Indices

Nifty

24,793.25 -18.80
(-0.08%)

Sensex

81,361.87 -82.79
( -0.10%)

Bank Nifty

55,577.45 -251.30
( -0.45%)

Nifty IT

38,664.95 -365.95
( -0.94%)

Global Indices

Nasdaq

42,197.27 -39.54
(-0.09%)

Dow Jones

6,001.75 -1.97
(-0.03%)

Hang Seng

38,513.67 -371.48
(-0.96%)

Nikkei 225

8,791.80 -51.67
(-0.58%)

Forex

USD-INR

86.25 0.22
(0.26%)

EUR-INR

99.47 -0.03
(-0.03%)

GBP-INR

116.59 -0.20
(-0.17%)

JPY-INR

0.59 0.00
(-0.18%)

YOU ARE HERE :
HOME
Markets
Equity
Corporate Results - Detailed News

EQUITY - MARKET SCREENER

Back

Indrayani Biotech reports consolidated net loss of Rs 5.81 crore in the March 2025 quarter

17-Jun-25 07:29 Hrs IST

Net loss of Indrayani Biotech reported to Rs 5.81 crore in the quarter ended March 2025 as against net profit of Rs 3.87 crore during the previous quarter ended March 2024. Sales rose 13.95% to Rs 50.57 crore in the quarter ended March 2025 as against Rs 44.38 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 4.52 crore in the year ended March 2025 as against net profit of Rs 6.36 crore during the previous year ended March 2024. Sales declined 21.66% to Rs 130.23 crore in the year ended March 2025 as against Rs 166.23 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	50.57	44.38	14	130.23	166.23	-22
OPM %	-11.35	22.94	-	4.81	14.11	-
PBDT	-10.03	5.69	PL	-2.38	14.78	PL
PBT	-8.32	4.73	PL	-5.74	10.97	PL
NP	-5.81	3.87	PL	-4.52	6.36	PL

24,793.25 -18.80 (-0.08%)

81,361.87 -82.79 ( -0.10%)

55,577.45 -251.30 ( -0.45%)

38,664.95 -365.95 ( -0.94%)

42,197.27 -39.54 (-0.09%)

6,001.75 -1.97 (-0.03%)

38,513.67 -371.48 (-0.96%)

8,791.80 -51.67 (-0.58%)

86.25 0.22 (0.26%)

99.47 -0.03 (-0.03%)

116.59 -0.20 (-0.17%)

0.59 0.00 (-0.18%)